AG2R La Mondiale Gestion d'Actifs’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.5M Buy
77,661
+6,686
+9% +$1.44M 0.71% 23
2026
Q1
$15.4M Buy
70,975
+940
+1% +$209K 0.7% 19
2025
Q4
$16M Buy
70,035
+4,114
+6% +$937K 0.71% 20
2025
Q3
$12.2M Hold
65,921
0.63% 24
2025
Q2
$12.2M Buy
65,921
+764
+1% +$142K 0.63% 24
2025
Q1
$12.1M Buy
+65,157
New +$12.7M 0.66% 23

Other funds holding ABBV

AG2R La Mondiale Gestion d'Actifs's ABBV Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs increased its AbbVie (ABBV) stake by 9.4% in Q2 2026, buying an estimated $1.44M and bringing the position to 77,661 shares worth $19.5M. The position accounts for 0.71% of the portfolio, ranked #23.

AG2R La Mondiale Gestion d'Actifs first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • AG2R La Mondiale Gestion d'Actifs held 77,661 shares of AbbVie worth $19.5M as of Q2 2026.
  • AG2R La Mondiale Gestion d'Actifs bought 6,686 AbbVie shares in Q2 2026, an estimated $1.44M.
  • AbbVie made up 0.71% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #23 holding.
  • AG2R La Mondiale Gestion d'Actifs first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.